TestoPrime Reviews: Best Testosterone Booster Supplement For Men Over 40 & 50 Is TestoPrime Tablets Safe?
GLASGOW, United Kingdom, April 11, 2025 (GLOBE NEWSWIRE) -- There are relatively…
Afcons Infrastructure wins Global ‘Most Innovative Knowledge Enterprise’ Award
MUMBAI, India, March 19, 2025 /PRNewswire/ -- Afcons Infrastructure Ltd has won…
Businesses across India are engaging independent talent at rates ranging from INR 10,000 to 30,000 per day to scale faster: Outsized’s 2025 Talent-on-Demand Report reveals critical hiring trends and most in-demand skills
MUMBAI, India, March 17, 2025 /PRNewswire/ -- Companies across India are increasingly…
Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025
- The late-breaking oral presentation at SGO 2025 highlights consistent response rates…
Apex by Arya.ai: Advanced APIs for Intelligent AI Agents
MUMBAI, India and NEW YORK, Feb. 17, 2025 /PRNewswire/ -- AI Agents are…
NKGen Biotech Announces Publication of Phase 1 Troculeucel Clinical Trial Results for the Treatment of Alzheimers Disease
February 13, 2025 08:00 ET | Source: NKGen Biotech The results from…
Corti’s First AId Report: Burnout levels challenge healthcare professionals’ ability to care for patients in Europe and the U.S.
Artificial Intelligence could be a lifeline but unsuccessful trials, limited opportunities, and…
Euroclear continues to deliver strong results in 2024
BRUSSELS, Feb. 5, 2025 /PRNewswire/ -- Results for the year ending 31…
Xilio Therapeutics Announces Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer
27% preliminary response rate observed in heavily pre-treated microsatellite stable colorectal cancer…